Profile of viral load, integration, and E2 gene disruption of HPV58 in normal cervix and cervical neoplasia

被引:30
作者
Chan, Paul K. S. [1 ]
Cheung, Jo L. K.
Cheung, Tak-Hong
Lo, Keith W. K.
Yim, So-Fan
Siu, Shing-Shun N.
Tang, Julian W.
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Sch Publ Hlth, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1086/520884
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The clinical utility of viral-load and integration status of human papillomavirus (HPV) infection remains uncertain. We examined 75 women infected with HPV58, a worldwide rare type found to be prevalent in cervical cancers in eastern Asia. Viral load was significantly higher for cervical intraepithelial neoplasia (CIN) 1/2, but those for a normal control group and for CIN 3 or cancer overlapped substantially. A pure integrated genome was found for all lesion grades, giving a poor positive predictive value (23.1%) for cancer. The pure episomal form's negative predictive value for cancer was only 76.3%. Mixed patterns of E2 gene disruption were common and often involved the amino-terminal and hinge regions. Disruption of the whole E2 gene was rare and was restricted to high-grade lesions. The HPV58 variant E67-HK-2 was more likely to exist in the pure episomal form. Routinely collected cervical samples contain a heterogeneous population of viruses, hampering the application of viral load and integration testing in clinical settings.
引用
收藏
页码:868 / 875
页数:8
相关论文
共 41 条
  • [1] Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN)
    Andersson, S
    Safari, H
    Mints, M
    Lewensohn-Fuchs, I
    Gyllensten, U
    Johansson, B
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (12) : 2195 - 2200
  • [2] Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer
    Arias-Pulido, Hugo
    Peyton, Cheri L.
    Joste, Nancy E.
    Vargas, Hernan
    Wheeler, Cosette M.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (05) : 1755 - 1762
  • [3] HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness
    Badaracco, G
    Venuti, A
    Sedati, A
    Marcante, ML
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (04) : 574 - 582
  • [4] Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil
    Camara, GNL
    Cerqueira, DM
    Oliveira, APG
    Silva, EO
    Carvalho, LGS
    Martins, CRF
    [J]. MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2003, 98 (07): : 879 - 883
  • [5] Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers
    Chan, PKS
    Cheung, TH
    Tam, AOY
    Lo, KWK
    Yim, SF
    Yu, MMY
    To, KF
    Wong, YF
    Cheung, JLK
    Chan, DPC
    Hui, M
    Margaret, IP
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (01) : 243 - 245
  • [6] Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249
  • [7] Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in Southern China
    Chan, PKS
    Lam, CW
    Cheung, TH
    Li, WWH
    Lo, KWK
    Chan, MYM
    Cheung, JLK
    Xu, LY
    Cheng, AF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (05) : 696 - 700
  • [8] Chan PKS, 1999, J MED VIROL, V59, P232, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt
  • [9] 232::AID-JMV18&gt
  • [10] 3.0.CO